Thane Wettig

Chief Commercial Officer at FibroGen, Inc.

Thane Wettig

Thane Wettig

Chief Commercial Officer at FibroGen, Inc.

Biography

Thane Wettig is Chief Commercial Officer at FibroGen, Inc. He previously occupied the position of Chief Commercial Officer of Intarcia Therapeutics, Inc. Mr. Wettig received an undergraduate degree and an MBA from Washington University in St. Louis.

Overview
RelSci Relationships

633

Contact Data
Trying to get in touch with Thane Wettig? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Thane Wettig likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at FibroGen, Inc.

Relationship likelihood: Strong

Interim President at FibroGen, Inc.

Relationship likelihood: Strong

Executive Director, Clinical Development at FibroGen, Inc.

Relationship likelihood: Strong

Chief Financial Officer & Chief Accounting Officer at FibroGen, Inc.

Relationship likelihood: Strong

Executive Director at FibroGen, Inc.

Relationship likelihood: Strong

Executive Director at FibroGen, Inc.

Relationship likelihood: Strong

Chief Scientific Officer at FibroGen, Inc.

Relationship likelihood: Strong

Chief Medical Officer at FibroGen, Inc.

Relationship likelihood: Strong

Chief Intellectual Property Officer at FibroGen, Inc.

Relationship likelihood: Strong

Chief Business Officer at FibroGen, Inc.

Relationship likelihood: Strong

Paths to Thane Wettig
Potential Connections via
Relationship Science
You
Thane Wettig
Chief Commercial Officer at FibroGen, Inc.
Education

The mission of Washington University in St. Louis is the promotion of learning — learning by students and by faculty. Teaching, the transmission of knowledge, is central to our mission, as is research, the creation of new knowledge. Faculty — composed of scholars, scientists, artists and members of the learned professions — serve society by teaching; by adding to the store of human art, creativity, understanding, and wisdom; and by providing direct services, such as health care. The university offers more than 90 programs and almost 1,500 courses leading to bachelor's, master's and doctoral degrees in a broad spectrum of traditional and interdisciplinary fields, with additional opportunities for minor concentrations and individualized programs.

Career History
Marketing Manager
Prior

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. Its products include Forteo, Adrica, BAQSIMI, Basaglar and Glucagn. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

Chief Commercial Officer
2018 - Prior

Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.

Chief Commercial Officer
2020 - Current

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$500 - $999
2012

Second Helpings, Inc. collects prepared and perishable food from wholesalers, retailers and restaurants for preventing unnecessary waste. The company was founded by Kristen Cordoza, Bob Koch and Jean Paison in 1998 and is headquartered in Indianapolis, IN.

Transactions
Details Hidden

Intarcia Therapeutics, Inc. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Thane Wettig. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Thane Wettig's profile does not indicate a business or promotional relationship of any kind between RelSci and Thane Wettig.